Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04044534
PHASE2

Intranasal Insulin for Posttraumatic Stress Disorder

Sponsor: VA Connecticut Healthcare System

View on ClinicalTrials.gov

Summary

To evaluate if intranasal insulin is effective in reducing PTSD symptoms.

Official title: Intranasal Insulin for Treating Posttraumatic Stress Disorder

Key Details

Gender

All

Age Range

21 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2024-10-31

Completion Date

2026-05-31

Last Updated

2025-09-16

Healthy Volunteers

No

Conditions

Interventions

DRUG

Intranasal insulin

Subjects in this arm will receive intranasal insulin (80 IU per day).

DRUG

Placebo

Subjects in this arm will receive placebo.

Locations (1)

VA Connecticut Healthcare System

West Haven, Connecticut, United States